Antra Jurka

Dr. Antra Jurka


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Gita ErtaGita Erta
Gita Erta
GGGita Gersone
Gita Gersone
AJAntra Jurka
Antra Jurka
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
Salivary α-amylase, primarily encoded by the AMY1 gene, initiates the enzymatic digestion of dietary starch in the oral cavity and has recently emerged as a potential biomarker in metabolic research. Variability in salivary amylase activity (SAA), driven largely by copy number variation of AMY1, has been associated with postprandial glycemic responses, insulin secretion dynamics, and susceptibility to obesity. This review critically examines current analytical approaches for quantifying SAA, including enzymatic assays, colorimetric techniques, immunoassays, and emerging biosensor technologies. The methodological limitations related to sample handling, intra-individual variability, assay standardization, and specificity are highlighted in the context of metabolic and clinical studies. Furthermore, the review explores the physiological relevance of SAA in energy homeostasis and its associations with visceral adiposity and insulin resistance. We discuss the potential integration of SAA measurements into obesity risk stratification and personalized dietary interventions, particularly in individuals with altered starch metabolism. Finally, the review identifies key research gaps and future directions necessary to validate SAA as a reliable metabolic biomarker in clinical practice. Understanding the diagnostic and prognostic value of salivary amylase may offer new insights into the prevention and management of obesity and related metabolic disorders.

Verified
Journal Article
Open access
PDF file
Gita ErtaGita Erta
Gita Erta
GGGita Gersone
Gita Gersone
AJAntra Jurka
Antra Jurka
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
The prevalence of overweight and obesity in women of reproductive age leads to significant health risks, including adverse metabolic and reproductive outcomes. Effective dietary interventions are critical to improving health outcomes in this population. This study investigates the impact of a 12-week diet intervention on metabolic markers of adipose tissue in overweight women of reproductive age, determining whether calorie restriction or low-starch diets are more effective, while also accounting for salivary amylase activity. A total of 67 overweight women of reproductive age were enrolled in a randomized controlled trial (RCT). Participants were divided into high-salivary-amylase (HSA) and low-salivary-amylase (LSA) groups based on baseline salivary amylase activity measured using a spectrophotometric method. Each group was further subdivided into two dietary intervention groups: calorie restriction (CR) and low starch (LS), resulting in four subgroups (HSA-CR, HSA-LS, LSA-CR, LSA-LS), along with a control group (CTR) of normal-weight individuals (no intervention). Participants were assigned to a calorie-restricted diet or a low-starch diet for 12 weeks. Key metabolic markers of adipose tissue, including insulin sensitivity, adipokines, cytokines, and lipid profiles, were measured at baseline (T0), 30 min after consuming starch-containing muesli (T1), and 12 weeks after intervention (T2). Active GLP-1, glucagon, and C-peptide levels were assessed to clarify the hormonal mechanisms underlying the dietary effects. Salivary amylase activity was also measured to examine its role in modulating glucose and GLP-1 responses. Both diet interventions led to significant improvements in metabolic markers of adipose tissue, though different ones. Calorie restriction improved insulin sensitivity by effectively reducing visceral fat mass and enhancing insulin signaling pathways. In contrast, the low-starch diet was linked to a reduction in the coefficient of glucose variation influenced partly by changes in GLP-1 levels. Our findings highlight the importance of personalized diet strategies to optimize metabolic health in this demographic.

Verified
Journal Article
Open access
PDF file
Gita ErtaGita Erta
Gita Erta
GGGita Gersone
Gita Gersone
AJAntra Jurka
Antra Jurka
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
Butyrate, a short-chain fatty acid (SCFA) produced by the fermentation of dietary fibers in the colon, plays a pivotal role in regulating metabolic health, particularly by enhancing insulin sensitivity. Given the rising incidence of metabolic disorders, understanding the factors that influence butyrate production is of significant interest. This study explores the link between salivary amylase activity and butyrate levels in overweight women of reproductive age. Participants were categorized into low (LSA) and high (HSA) salivary amylase activity groups and further divided into two subgroups: one followed a low-starch diet (LS), and the other underwent caloric restriction (CR). We assessed salivary amylase activity and measured serum butyrate concentrations to examine their associations. Our findings showed a significant, though weak, positive correlation (ρ = 0.0486, p < 0.05), suggesting a link between salivary amylase activity and butyrate levels. The statistical significance, despite the weak correlation, implies that this relationship is not random. Moreover, higher baseline butyrate levels were observed in women with elevated salivary amylase activity. Also, women with low salivary amylase activity on a low-starch diet experienced a more pronounced increase in butyrate levels compared to those on caloric restriction. These results suggest that salivary amylase activity and dietary intake interact to influence butyrate production, with potential implications for improving insulin sensitivity and metabolic health. The study underscores the potential of butyrate in enhancing insulin sensitivity and promoting overall metabolic well-being. Further research is necessary to clarify the mechanisms involved and to understand the long-term effects of butyrate on metabolic health across different populations.

26 September 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
APAelita Plinta
Aelita Plinta
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
SSSimons Svirskis
Simons Svirskis
ILInara Logina
Inara Logina
GGGita Gersone
Gita Gersone
GBGuntis Bahs
Guntis Bahs
The aim of the study was to clarify correlations between body mass index (BMI), blood pressure (BP), and serum levels of cytokines in female migraine patients. A total of 14 migraineurs with aura, and 12 without aura during their interictal period were compared with 25 controls. Interleukin-8 (IL-8), soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), matrix metalloproteinase-9 (MMP-9), interferon gamma (IFN-γ), monocyte chemoattractant protein-1 (MCP-1), transforming growth factor alpha (TGF-α), and plasminogen activator inhibitor-1 (PAI-1) were measured. Migraineurs have elevated levels of IL-8, but decreased serum levels of PAI-1 and sICAM-1 during the interictal period, regardless of aura. BMI correlates with BP, and also with IFN-γ and MMP-9 only in patients with aura. There are three correlations in migraine patients with aura that are absent in patients without aura: between IL-8 and PAI-1; MMP-9 and IL-8; and IL-8 and sICAM-1. Migraineurs without aura, on the other hand, have correlations that patients with aura do not have (between PAI-1 and MCP-1, sICAM-1; between MMP-9 and sICAM-1, MCP-1; between TGF-α and PAI-1, MMP-9, sICAM-1; between sICAM-1 and MMP-9, PAI-1, MCP-1; as well as between sVCAM-1 and MCP-1). PAI-1, TGF, and MMP-9 could be used as biomarkers to distinguish migraineurs from healthy individuals.

17 August 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
VBVanda Bondare-Ansberga
Vanda Bondare-Ansberga
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
SSSimons Svirskis
Simons Svirskis
AJAntra Jurka
Antra Jurka
IMIndra Mikelsone
Indra Mikelsone
IHIlona Hartmane
Ilona Hartmane
Background/Objectives: Psoriasis is a systemic immune-mediated inflammatory disease associated with endothelial dysfunction and cardiovascular risk. This study evaluated relationships among clinical severity, cytokine activity, systemic vascular resistance, and skin microvascular reactivity in chronic plaque psoriasis before and after therapy. Methods: In this prospective longitudinal study, 34 patients with chronic plaque psoriasis and 19 matched controls were assessed. Patients were examined at baseline and after 12 months of clinically indicated systemic therapy. Psoriasis Area and Severity Index (PASI), serum IL-17A, IL-22, TNF-α, IL-12(p40), IL-10, VEGF-A, total peripheral resistance, and laser Doppler flowmetry post-occlusive reactive hyperemia indices were analysed. Results: PASI decreased markedly after therapy, from 20.6 ± 7.7 to 4.1 ± 5.3, with excellent discrimination between pre- and post-treatment states. IL-17A, IL-22, and IL-12(p40) decreased significantly, while TNF-α remained associated with disease severity. Total peripheral resistance and delayed psoriatic-skin hyperemia persisted and correlated with inflammatory/angiogenic markers, particularly IL-12(p40) and VEGF-A. Conclusions: Long-term therapy improves clinical and cytokine profiles in psoriasis, but vascular dysfunction may persist despite cutaneous improvement. Integrated cytokine–vascular assessment may complement PASI for evaluating systemic inflammatory burden and cardiovascular risk.

30 September 2025 in Medicina
Verified
Journal Article
Open access
PDF file
Valters VegelisValters Vegelis
Valters Vegelis
IMIeva Anna Miezaja
Ieva Anna Miezaja
IMIndra Mikelsone
Indra Mikelsone
AJAntra Jurka
Antra Jurka
Background and Objectives: Acute exercise lowers vagal HRV, yet it is unclear who will show the largest drop and whether simple questionnaires can identify them. To test whether resting HRV complexity (Sample Entropy) predicts the magnitude of acute vagal withdrawal and whether this physiology-based marker has greater practical utility than self-report activity/sleep measures for screening and recovery decisions. Materials and Methods: In a single-arm pre–post experimental study, twenty-nine students (20.4 ± 0.5 y; 13 males, 16 females) completed one morning visit (08:00–12:00 h). After a 2 min resting ECG and a Sustained Attention to Response Task (SART), participants cycled 15 min at 0.85 × (220 − age) bpm following a 5 min 25 W warm-up. HRV was re-recorded within ~2 min and SART ~5 min post exercise. The IPAQ defined low/medium/high activity tertiles. Correlations related baseline measures to change scores. Results: RMSSD decreased by −12.93 ms [−25.71, −2.03] (p = 0.003, r = 0.60) and SDNN by −14.91 ms [−22.30, 7.66] (p = 0.011, r = 0.51). Reaction time shortened slightly (−8.77 ms [−59.33, 30.40], p = 0.35). Activity tertiles did not differ in ΔRMSSD, ΔSDNN, or ΔRT (all p > 0.10). Sample Entropy predicted autonomic change (ΔRMSSD r = 0.43, p = 0.034; ΔSDNN r = 0.59, p = 0.002), whereas the PSQI and IPAQ did not. Equivalence tests showed non-significant tertile differences were not within our predefined equivalence bounds. Conclusions: Individuals with more complex resting HRV were more likely to show a larger immediate vagal withdrawal after moderate cycling. Questionnaires did not identify these responders. Non-linear HRV may aid practical screening/monitoring, whereas self-reports alone appear insufficient. Generalizability is limited by the homogeneous young adult sample.